| BCLI Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the BCLI market cap history going back to 8/4/2014:
Also see: BCLI Shares Outstanding History and BCLI YTD Return |
BCLI Market Cap History — Brainstorm Cell Therapeutics Capitalization Over Time
As of 5/11/2026 Brainstorm Cell Therapeutics has a market cap of 7.39 million. Investors often follow the BCLI market cap history to compare the size of the company over time.
This page shows BCLI market capitalization trends over time, with 50 market cap datapoints presented, dating back to 8/4/2014.
| BCLI Market Cap History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
BCLI Historical Market Cap: -17.65% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| BCLI Stock Price Chart |
| About Brainstorm Cell Therapeutics Inc |
| BrainStorm Cell Therapeutics Inc. is a developer of autologous adult stem cell therapeutics for debilitating neurodegenerative diseases. The neurodegenerative diseases include Amyotrophic Lateral Sclerosis (ALS), Progressive Multiple Sclerosis (PMS), Alzheimer's disease (AD), and others. Co. is engaged in the clinical development and commercialization of the NurOwn technology platform used to produce autologous mesenchymal stem cells- neurotrophic factors (MSC-NTF) cells. We show 50 historical shares outstanding datapoints in our BCLI shares outstanding history coverage, used to compute BCLI market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing BCLI market cap history over the course of time is important for investors interested in comparing BCLI's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of BCLI versus a peer is one thing; comparing BCLI market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like BCLI can fluctuate over the course of history. With this page we aim to empower investors researching BCLI by allowing them to research the BCLI market cap history. |
| BCLI Current Stock Quote |
Quotes delayed 20 minutes  Free BCLI Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: The Importance of Market Cap | |
|
Video: The Importance of Market Cap
| BCLI Share Performance |
| Market Cap Peers |
| Brainstorm Cell Therapeutics (BCLI) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
BCRX Market Cap History BDSI Market Cap History BDSX Market Cap History BDTX Market Cap History BDX Market Cap History BEAM Market Cap History BEAT Market Cap History BFLY Market Cap History BFRG Market Cap History BFRI Market Cap History More Healthcare companies » |
BCLI Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
